Epstein-Barr virus and Hodgkin lymphoma in Jordan

Hematol Oncol Stem Cell Ther. 2014 Jun;7(2):85-9. doi: 10.1016/j.hemonc.2013.12.002. Epub 2014 Jan 25.

Abstract

Background and objectives: This study aims to examine the possible association of Epstein-Barr virus (EBV) in Classical Hodgkin lymphoma (cHL) and to shed light on the epidemiology of Hodgkin lymphoma (HL) in Jordan.

Patients and methods: We examined 100 consecutive cases of HL for the presence of EBV in tumor cells by immunohistochemistry for latent membrane protein-1 (LMP-1). We collected patient data on age, sex and histologic subtype. We reviewed the pathological findings in each case and confirmed diagnosis.

Results: Nodular lymphocyte predominant HL was diagnosed in 6% of the cases and these were negative for EBV LMP-1. Of the 94 cases of cHL, 65% were males, the most common subtype was nodular sclerosis (NS), representing 70% of the cases, and 45.7% of cHL (43% of all HL) cases were positive for EBV LMP-1. The positive cases were significantly related to age: ⩽15 years and >51 years (p: 0.009 and 0.014 respectively), male gender (p: 0.03) and mixed cellularity (MC) subtype (p: <0.0001). In line with other developing countries, there also appears to be a trend towards a decreasing association of EBV with cHL and a subtype switch from MC to NS in Jordan.

Conclusion: The epidemiology of HL in Jordan and some developing countries is approaching that of developed countries.

Keywords: EBV; Hodgkin lymphoma; Jordan.

MeSH terms

  • Adolescent
  • Adult
  • Epstein-Barr Virus Infections / complications
  • Epstein-Barr Virus Infections / epidemiology*
  • Female
  • Hodgkin Disease / epidemiology*
  • Hodgkin Disease / virology*
  • Humans
  • Immunohistochemistry
  • Jordan / epidemiology
  • Male
  • Middle Aged
  • Young Adult